FARMINGTON, Conn., June 21, 2018 /PRNewswire-PRWeb/ -- Mobile Sense Technologies, Inc. (Mobile Sense) today announced
The startup continues to expand development of its wearable technology to detect arrhythmias for use in a broader population. Co-founder and UConn professor of biomedical engineering, Ki Chon, PhD, pioneered the patent portfolio and leads algorithm development.
Mobile Sense is building foundational technology enabling off-the-chest wearables for long-term management of cardiac arrhythmias. The traditional cardiac monitoring market relies on seeing a specialist known as an electrophysiologist (EP) to make a diagnosis. Mobile Sense enables users to do a first pass screen of their own cardiac signals using smart watch technology, with the possibility for long-term monitoring on the upper arm as prescribed by a cardiologist.
Located at UConn's Technology Incubation Program facility in Farmington, Connecticut, Mobile Sense Technologies also recently won $225,000 from the National Science Foundation's Small Business Research Innovation (SBIR) program, award 1746589.
This Phase I funding will allow Mobile Sense to further optimize their technology for commercial use. The primary goal of the proposal is to understand how electromyogram (EMG) physiological interference from the bicep and tricep muscles can be registered without inaccurately appearing in the electrocardiogram (ECG) signal on the arm, as well as to embed motion and noise cancellation into Mobile Sense's armband-based device.
"We're thrilled about these two major milestones – winning additional protection for our novel technology and receiving additional non-dilutive funding to continue to commercialize it," says Justin Chickles, CEO and cofounder. "This type of progress brings us that much closer to a viable product that can provide physicians with critical information and patients with improved quality of life."
Arrhythmias are one of the leading causes of strokes and affect 120 million people worldwide. In the United States, six million people are affected; two million of whom are identifiable and symptomatic.
Mobile Sense aims to expand diagnosis of patients with arrhythmias that are random onset and/or asymptomatic through long term, non-invasive health monitoring.
Mobile Sense is also currently enrolling patients at a clinical study at the University of Massachusetts Memorial Medical Center by lead investigator Dr. Timothy Fitzgibbons with input from co-inventor and Section Chief, Connected Cardiovascular Healthcare, Dr. David McManus. The National Institutes for Health Small Business Innovation Research (SBIR) program is funding this study, award R43HL135961.
"Mobile Sense Technologies and their continued progress show what can be achieved when industry and academia come together to move technologies forward," says Radenka Maric, vice president for research. "The combination of top researchers, experienced business experts, and the entrepreneurial ecosystem fostered at UConn can lead to solutions for the health of our citizens as well as our economy."
About Mobile Sense Technologies, Inc. Mobile Sense provides platform technology enabling off-the-chest medical wearables for highly sensitive and specific detection and long-term management of cardiac arrhythmias by peering through the noise to capture clear signals. They are replacing today's invasive and inconvenient cardiac monitoring technology which includes wires and patches, with simple easy to use, wearable devices. Mobile Sense is led by CEO and Co-Founder, Justin Chickles, a serial entrepreneur and startup veteran and former medical device innovator and leader at Johnson & Johnson. Prof. Ki. Chon, Chair of Biomedical Engineering at the University of Connecticut, is the CTO and Co-Founder of Mobile Sense and developed the technology while at the University of Connecticut, Worcester Polytech Institute, and the State University of New York. Mobile Sense investors include Connecticut Innovations and angel investors. Mobile Sense is in process of raising their Series A - http://www.mobilesensetech.com/
About UConn's Technology Incubation Program (TIP) UConn's Technology Incubation Program (TIP) is the only university-based technology business incubation program in Connecticut. Established in 2004, TIP couples UConn's world-class research resources, facilities, and business support services with a network of experienced investors and entrepreneurs to help launch high-potential startups. Since 2004, the program has helped over 90 companies that have raised more than $50 million in grants and $135 million in equity and debt. https://tip.uconn.edu/
About the NSF SBIR - America's Seed Fund NSF's SBIR program provides non-dilutive funds for early-stage research and development (R&D) at small businesses. This R&D should be based on innovative, transformational technology with potential for substantial commercial and/or societal benefits. The program invites proposals from small businesses across a broad range of science and engineering disciplines. This material is based upon work supported by the National Science Foundation under award no. 1746589. https://seedfund.nsf.gov/
About the NIH SBIR The NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs award federal research grants and contracts to small businesses conducting biomedical research. The purpose of these programs is to commercialize innovative technologies that improve health and save lives. Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number R43HL135961. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. https://sbir.nih.gov
SOURCE Mobile Sense Technologies
Subscribe to our Free Newsletters!
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...
Blount's disease is a developmental disorder in which the shinbone is affected, resulting in ...View All